Hardwiring antimicrobial resistance mitigation into global policy
dc.contributor.author | Thornber, K | |
dc.contributor.author | Kirchhelle, C | |
dc.date.accessioned | 2022-09-15T08:49:42Z | |
dc.date.issued | 2022-08-02 | |
dc.date.updated | 2022-09-14T15:51:00Z | |
dc.description.abstract | In the wake of COVID-19, antimicrobial resistance (AMR) has become termed the 'silent pandemic', with a growing number of editorials warning that international momentum for AMR mitigation is being lost amidst the global turmoil of COVID-19, economic crises and the climate emergency. Yet, is it sufficient to now simply turn the volume of the pre-existing AMR policy discourse back up? Although existing AMR initiatives have previously achieved high levels of international attention, their impact remains limited. We believe it is time to critically reflect on the achievements of the past 7 years and adapt our AMR policies based on the substantial literature and evidence base that exists on the socioecological drivers of AMR. We argue that developing a more sustainable and impactful response requires a shift away from framing AMR as a unique threat in competition with other global challenges. Instead, we need to move towards an approach that emphasizes AMR as inherently interlinked and consciously hardwires upstream interventions into broader global developmental agendas. | en_GB |
dc.description.sponsorship | University of Exeter | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Norwegian Research Council | en_GB |
dc.identifier.citation | Vol. 4(4), article dlac083 | en_GB |
dc.identifier.doi | https://doi.org/10.1093/jacamr/dlac083 | |
dc.identifier.uri | http://hdl.handle.net/10871/130839 | |
dc.language.iso | en | en_GB |
dc.publisher | Oxford University Press (OUP) / British Society for Antimicrobial Chemotherapy | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/35928475 | en_GB |
dc.rights | © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | en_GB |
dc.title | Hardwiring antimicrobial resistance mitigation into global policy | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2022-09-15T08:49:42Z | |
dc.identifier.issn | 2632-1823 | |
exeter.place-of-publication | England | |
dc.description | This is the final version. Available on open access from Oxford University Press via the DOI in this record | en_GB |
dc.identifier.eissn | 2632-1823 | |
dc.identifier.journal | JAC-Antimicrobial Resistance | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dc.rights.license | CC BY | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2022-08-02 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2022-09-15T08:47:08Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2022-09-15T08:49:55Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2022-08-02 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.